India has recommended the use of Bharat Biotech’s COVID-19 to children below 12 years old.
Bharat Biotech’s vaccine is the first vaccine to receive such approval following a review of its trial data for children ages two to 18.
The decision comes as India focuses on vaccinating youngsters against the coronavirus, having already administered over 950 million doses to adults in its nearly 1.4 billion-strong population.
However, it will not be an accepted vaccine around the world.
“Children with comorbidities should be vaccinated as soon as possible now that a vaccine with immunogenicity in children and a large safety database in adults is available,” said Dr. Gagandeep Kang, professor at Christian Medical College, Vellore.
“For healthy children, given low risk and low virus circulation at the moment, it is safe to wait until more adults are covered,” Kang added.
A good recommendation was made by the Central Drugs Standard Control Organisation and Subject Expert Committee after reviewing the data for the children ages two to 18.
© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.